| Literature DB >> 26552870 |
Naglaa Gamil Shehab1, Eman Abu-Gharbieh2, Fatehia A Bayoumi3.
Abstract
BACKGROUND: Flavonoids and other polyphenols play a protective role in liver diseases and possess a high antioxidant capacity.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26552870 PMCID: PMC4640355 DOI: 10.1186/s12906-015-0919-6
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
Animals groups and corresponding treatment with vehicle, tested samples and carbon tetrachloride
| Oral treatment | Frequency | i.p. CCl4 injection | |
|---|---|---|---|
| Control | Vehicle | daily | - |
| CCl4 control | Vehicle | daily | 1.0ml/kg |
|
| 10 mg/kg | Twice daily | - |
| 5mg/kg | daily | 1.0 ml/kg | |
| 10 mg/kg | daily | 1.0 ml/kg | |
|
| 500 mg/kg | Twice daily | - |
| 250 mg/kg | daily | 1.0 ml/kg | |
| 500 mg/kg | daily | 1.0 ml/kg | |
|
| 200 mg/kg | Twice daily | - |
| 100 mg/kg | daily | 1.0 ml/kg | |
| 200 mg/kg | daily | 1.0 ml/kg | |
|
| 500 mg/kg | Twice daily | - |
| 250 mg/kg | Daily | 1.0 ml/kg | |
| 500 mg/kg | Daily | 1.0 ml/kg |
Total Flavonoid and phenolic acid contents of the different extracts of Fagonia indica, Calotropis procera, Zygophyllum hamiense and S.imbricata
| Plant name | Total flavonoid content g quercetin/100 g | Total phenolic content mg GAE/g | ||||||
|---|---|---|---|---|---|---|---|---|
| Methanol extract | Ethanol extract | Acetone extract | Ethyl acetate extract | Methanol extract | Ethanol extract | Acetone extract | Ethyl acetate extract | |
|
| 0.22 | 3.00 | 0.32 | 0.10 | 3.91 | 4.00 | 2.1 | 0.75 |
|
| 0.12 | 0.3 | 0.90 | 0.10 | 3.13 | 4.00 | 4.00 | 0.92 |
|
| 0.38 | 0.14 | 1.48 | 0.11 | 2.60 | 3.61 | 1.20 | 4.00 |
|
| 0.571 | 0.217 | 0.374 | 0.11 | 2.60 | 0.64 | 4.00 | 0.93 |
aResults previously reported [39]
Phenolics identified by RP-HPLC analysis (at = 280 nm) of the methanolic extracts of Fagonia indica, Calotropis procera, Zygophyllum hamiense and S.imbricata
| Retention time | Identified constituent | Relative area % | |||
|---|---|---|---|---|---|
|
|
|
|
| ||
| 6.81 | Pyrogallol | 0.145 | 0.173 | 1.94 | - |
| 6.92 | Gallic acid | 0.05 | 0.27 | 2.02 | 0.145 |
| 8.235 | Protocatechuic acid | 0.12 | 0.504 | 0.97 | 0.068 |
| 8.444 | Catechin | - | 0.38 | 1.81 | 0.461 |
| 8.593 | Chlorogenic acid | 0.46 | 0.12 | 2.31 | 0.377 |
| 8.950 | Catechol | 0.16 | 0.44 | 2.57 | 0.329 |
| 10.040 | Caffeic acid | 0.25 | - | 1.54 | 1.759 |
| 11.073 | Vanillic acid | 0.37 | 0.82 | 1.37 | 0.286 |
| 11.620 | Ferulic acid | 0.34 | 0.36 | 0.84 | 1.323 |
| 12.466 |
| 0.73 | 1.53 | 1.1 | 1.154 |
| 12.943 |
| 1.20 | 1.20 | - | - |
| 13.127 | Benzoic acid | 1.02 | 1.59 | 1.51 | 2.306 |
| 13.789 | Coumaric acid | 0.51 | 0.52 | 1.2 | 4.251 |
| 14.980 | Cinnamic acid | 0.81 | 0.95 | - | 0.371 |
| 18.657 | Chrysin | 1.79 | 1.44 | 0.34 | 1.074 |
| Total identified constituents | 7.955 | 10.297 | 19.52 | 13.904 | |
aResults previously reported [39]
Phenolics identified by RP-HPLC analysis (at = 330 nm) of the methanolic extracts of Fagonia indica, Calotropis procera, Zygophyllum hamiense and S.imbricata
| Retention time | Identified constituent | Relative area % | |||
|---|---|---|---|---|---|
|
|
|
|
| ||
| 3.83 | Quercetin | 0.034 | 0.08 | 0.04 | 0.031 |
| 11.78 | Rosmarinic acid | 2.83 | 2.68 | 2.33 | 2.734 |
| 12.06 | Hesperidin | 1.21 | 2.22 | - | 1.854 |
| 12.44 | Rutin | - | 1.72 | 10.71 | 2.101 |
| 13.267 | Quercitrin | 5.29 | 4.16 | 0.77 | 12.692 |
| 14.576 | Naringenin | 1.36 | 1.15 | 0.94 | 1.300 |
| 14.952 | Hesperitin | 1.41 | - | - | 0.730 |
| 15.147 | Kampferol | 1.61 | 1.5 | - | - |
| 16.167 | Apigenin | 1.00 | 0.21 | - | 0.474 |
| Total identified constituents | 14.744 | 13.72 | 14.79 | 21.916 | |
aResults previously reported [39]
Fig. 1DPPH radical scavenging activity of several plants extracts
Evaluation of the hepatotoxic effect of the plant extracts on the biochemical parameters with twice daily oral administration in mice
| Control |
|
|
|
| |
|---|---|---|---|---|---|
| ALT | 290.1 ± 54.0 | 350.2 ± 113.6 | 155.3 ± 65.5 | 211.0 ± 35.8 | 253.3 ± 24.0 |
| AST | 850.0 ± 63.2 | 800.0 ± 235.8 | 520.3 ± 220.0 | 404.2 ± 37.2b | 653.3 ± 78.8 |
| ALP | 180.0 ± 20.3 | 113.3 ± 16.7a | 105.6 ± 15.4a | 98.2 ± 9.3b | 60.0 ± 23.1b |
| CAT kU/g protein | 462.0 ± 21.1 | 461.6 ± 14.9 | 428.750 ± 10.3 | 413.950 ± 11.4 | 486.3 ± 18.0 |
| GSH-Px U/g protein | 1.3 ± 0.1 | 1.3 ± 0.05 | 1.3 ± 0.07 | 1.6 ± 0.06 | 1.31 ± 0.14 |
| SOD μg/g protein | 34.6 ± 2.9 | 35.5 ± 2.7 | 32.8 ± 1.1 | 35.5 ± 1.4 | 32.1 ± 1.4 |
| TBARS (nmol/g prot.) | 0.49 ± 0.02 | 0.39 ± .03 | 0.046 ± 0.03 | 0.038 ± 0.02 | 0.035 ± 0.4 |
aSignificant difference (p < 0.05) compared to control group; bSignificant difference (p < 0.01) compared to control group
Fig. 2Histopathological findings of mice liver sections (PAS x400); (a) treated with 10 mg/kg F. indica twice daily showing excess glycogen synthesis; (b) negative control group treated with CCl4 alone showing dense periportal and lobular lymphocytic infiltrate with pyknotic nuclei within necrotic hepatocytes in periportal areas and some other cells show degenerative changes; (c) treated with 10mg/kg F. indica and CCl4 showing normal regenerating hepatocytes sometimes binucleated; (d) treated with 200mg/kg C. procera and CCl4 showing normal glycogen storage, stimulates regeneration and renewal of hepatocytes; (e) treated with 500mg/kg S. imbricata and CCl4 showing slight glycogen depletion and (f) treated with Z. hamiense Schweinf and CCl4 showing glycogen depletion in centrizonal area and more glycogen and ballooning degeneration on peripheral zone
Evaluation of the protective effect of the plants extracts on the biochemical parameters of liver in CCl4-induced hepatic damage in mice
| Control | CCl4 control |
|
|
|
| |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 5 mg/kg | 10 mg/kg | 250 mg/kg | 500 mg/kg | 100 mg/kg | 200 mg/kg | 250mg/kg | 500mg/kg | |||
| ALT (U/L) | 290.1 ± 54.0 | 1736.7 ± 161.2a | 2166.7 ± 157.8b | 1064.0 ± 264.9c | 1416.7 ± 105.8 | 950.3 ± 84.4 | 1054.3 ± 117.5c | 801.7 ± 76.0c | 1135.0 ± 127.9c | 476.7 ± 151.0c |
| AST(U/L) | 850.0 ± 63.2 | 1736.7 ± 215.1a | 1310.0 ± 181.5b | 926.2 ± 258.6c | 756.7 ± 128.6c | 783.3 ± 80.1c | 787.8 ± 69.6c | 922.7 ± 65.4c | 647.5 ± 62.8c | 530.0 ± 120.8c |
| ALP(U/L) | 180.0 ± 20.3 | 150.2 ± 55.7 | 125.0 ± 22.5 | 124.3 ± 17.4 | 106.7 ± 24.0 | 113.3 ± 29.1 | 51.8 ± 4.7 | 59.5 ± 6.1 c | 110.0 ± 14.7 | 63.3 ± 8.8 |
| CAT kU/g protein | 462.0 ± 21.1 | 241.3 ± 11.4a | 307.2 ± 9.2c | 392.200 ± 9.4c | 225.1 ± 10.5 | 259.1 ± 5.1 | 324.7 ± 25.8b | 335.0 ± 25.0c | 356.2 ± 24.1c | 374.9 ± 10.7c |
| GSH-Px U/g protein | 1.3 ± 0.1 | 0.85 ± 0.06a | 1.1 ± 0.2 | 1.2 ± 0.2 | 0.72 ± 0.1 | 0.94 ± 0.2 | 1.4 ± 0.06 | 1.4 ± 0.06 | 0.91 ± 0.06 | 1.39 ± 0.19b |
| SOD μg/g protein | 34.6 ± 2.9 | 22.0 ± 2.4a | 26.7 ± 1.8 | 32.9 ± 1.6c | 21.1 ± 1.7 | 23.6 ± 1.5 | 22.7 ± 1.2 | 31.5 ± 1.1b | 24.8 ± 0.5 | 26.4 ± 1.3 |
| TBARS (nmol/g prot.) | 0.049 ± 0.02 | 0.54 ± 0.20a | 0.12 ± 0.09c | 0.085 ± 0.05c | 0.42 ± 0.2 | 0.36 ± 0.4 | 0.14 ± 0.07c | 0.06 ± 0.01c | 0.11 ± 0.05c | 0.071 ± 0.02c |
aSignificant difference (p < 0.01) compared to control group; bSignificant difference (p < 0.05) compared to CCl4 treated group; cSignificant difference (p < 0.01) compared to CCl4 treated group
Fig. 3Chemical structures of quercitrin and rosmarinic acid